Lyka Labs Share Price

NSE
LYKALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Lyka Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52.09% Gain from 52W Low
-0.1
TTM PE Ratio
High in industry
142.3
Price to Book Ratio
Above industry Median
7.8
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
1.2

Lyka Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Lyka Labs Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
41.16 Cr
30.11 Cr
27.77 Cr
32.56 Cr
27.99 Cr

Lyka Labs Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
112.65 Cr
96.47 Cr
196.18 Cr
87.81 Cr
64.58 Cr

Lyka Labs Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
1.91 Cr
1.29 Cr
-2.09 Cr
2.01 Cr
-0.62 Cr

Lyka Labs Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
-2.62 Cr
-13.15 Cr
38.44 Cr
-10.09 Cr
-62.62 Cr

Lyka Labs Ltd shareholding Pattern

Promoter
58.1%
Foreign Institutions
0.2%
Domestic Institutions
0.6%
Public
41.1%
Promoter
58.1%
Foreign Institutions
0.2%
Domestic Institutions
0.7%
Public
41%
Promoter
54.8%
Foreign Institutions
0.2%
Domestic Institutions
0.9%
Public
44.1%
Promoter
54.8%
Foreign Institutions
0.2%
Domestic Institutions
0.6%
Public
44.4%
Promoter
54.8%
Foreign Institutions
0.2%
Domestic Institutions
0.4%
Public
44.6%
Promoter
54.6%
Foreign Institutions
0.2%
Domestic Institutions
0.4%
Public
44.8%

Lyka Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
155.00
10Day EMA
158.00
12Day EMA
158.40
20Day EMA
157.80
26Day EMA
156.80
50Day EMA
152.60
100Day EMA
145.30
200Day EMA
136.40
5Day SMA
155.50
10Day SMA
161.80
20Day SMA
160.40
30Day SMA
155.20
50Day SMA
150.80
100Day SMA
145.90
150Day SMA
134.10
200Day SMA
130.20
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
64792 Rs
119720 Rs
Week Rs
99993 Rs
194645 Rs
Month Rs
155664 Rs
318108 Rs
Resistance & Support
151.11
Pivot
Resistance
First Resistance
154.96
Second Resistance
160.19
Third Resistance
164.04
Support
First Support
145.88
Second support
142.03
Third Support
136.80
Relative Strength Index
41.94
Money Flow Index
50.36
MACD
1.59
MACD Signal
3.79
Average True Range
8.26
Average Directional Index
25.11
Rate of Change (21)
5.75
Rate of Change (125)
38.83

Lyka Labs Ltd Company background

Founded in: 1976
Managing director: KUNAL NARENDRA GANDHI
Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. 83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US Airsep Corporation, US Coloplast, Denmark and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The Company is engaged in the business of pharmaceutical and related activities, including research.The company offers a broad range of antibiotics used as lifesavers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anticancer products, cardiovascular drugs and antiinflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification, it has invested in Relic Finance, a company carrying on the business of finance and merchant banking.A GOIrecognised Export House, it received the Certificate of Merit for its excellent export performance in 199394. In the same year, it received an award from CHEMEXCIL for its outstanding performance.During 199798, the companys administrative office plant at tarapur has been awarded ISO 9002 certification for its quality management system by SGS Yarsley International Certification Services Limited, UK.The production carried out at Bombay has been shifted to Tarapur and Ankleshwar in the year 19992000, inorder to achieve economies of scale and better compliance. The company has assigned Trade Marks and transferred technical, marketing knowhow and allied rights pertaining to some of its products.The Companys factory at Tarapur, recommissioned production in March, 2013. It launched Glutathione Injection, a First Time in India formulation during 201213. It commissioned the production at Ankleshwar factory. During Financial Year 201314, the Company had floated a Wholly Owned Subsidiary Company namely Lyka Healthcare Limited to focus, develop and expand Domestic Marketing of Ethical Products. Its another subsidiary, Lyka Exports Limited reorganized its activities and resultant, it sold the Animal Healthcare Business in 2014. The subsidiaries, Lyka Healthcare Limited and Lyka Exports Limited merged with the Company which became effective from April 01, 2016. During the year 202122, IPCA together with persons acting in concert acquired 26.70% shares of the Company through Public Offer consisting a total shareholding of 27.76% of the Paidup Equity Capital of the Company and resultant to acquisition in stake, became the Joint Promoters of Company.The Company has acquired the animal healthcare business of the Agilis Healthcare Private Limited in 2023.
Read More

Lyka Labs Ltd FAQs

Lyka Labs Ltd shares are currently priced at 148.9 on NSE and 148.75 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Lyka Labs Ltd [LYKALABS] share was 22.04. The Lyka Labs Ltd [LYKALABS] share hit a 1-year low of Rs. 97.9 and a 1-year high of Rs. 176.59.

The market cap of Lyka Labs Ltd is Rs. 534.42 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Lyka Labs Ltd is 134.82 as of 12/20/2024 12:00:00 AM.

The PB ratios of Lyka Labs Ltd is 4.08 as of 12/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 0.01% at the end of 12/20/2024 12:00:00 AM.

You can easily buy Lyka Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -